Biocompatibility study based on differential sequestration kinetics of CD14+CD16+ blood monocyte subsets with different dialyzers

Renal Failure

Volumn 28, Issue 6, 2006, Pages 493-499

  Griveas, Ioannis ^a,c   Visvardis, George ^a   Sakellariou, George ^a   Passadakis, Ploumis ^b   Thodis, Ilias ^b   Vargemezis, Vasilios ^b   Pavlitou, Aikaterini ^a   Fleva, Aleka ^a  

^a PAPAGEORGIOU GENERAL HOSPITAL   (Greece)

^b Nephrology Department   (Greece)

^c NONE   (Greece)

Author keywords

Biocompatibility; CD14+CD16+ monocytes; Dialyzers; Hemodialysis

Indexed keywords

ACETIC ACID DERIVATIVE; ACRYLONITRILE; ALPHA TOCOPHEROL; CUPROPHANE; METHACRYLIC ACID METHYL ESTER; POLYMER; SODIUM METHALLYLSULFONATE POLYMER; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; ARTIFICIAL KIDNEY; BIOCOMPATIBILITY; CD14+ CD16+ MONOCYTE; CELL SUBPOPULATION; CLINICAL ARTICLE; CONTROLLED STUDY; DIALYSIS MEMBRANE; FLOW CYTOMETRY; HEMODIALYSIS PATIENT; HUMAN; LEUKOCYTE COUNT; MONOCYTE; PRIORITY JOURNAL;

AGED; ANTIGENS, CD14; BIOCOMPATIBLE MATERIALS; HUMANS; KINETICS; LYMPHOCYTE COUNT; LYMPHOCYTE SUBSETS; MATERIALS TESTING; MEMBRANES, ARTIFICIAL; MIDDLE AGED; MONOCYTES; RECEPTORS, IGG; RENAL DIALYSIS;

EID: 33747764874     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.1080/08860220600781336     Document Type: Article

References (28)

1. Kaplow LS, Goffinet JA. Profound neutropenia during the early phase of hemodialysis. JAMA 1968;203:1135-1137.
2. Graddock PR, Freh J, Dalmasso AP, Grighm KL, Jacobs HS. Hemodialysis leukopenia: pulmonary vascular leukostasis resulting from complement activation by dialyzer cellophane membranes. J. Clin. Invest. 1977;59:879-888.
3. Stuard S, Carreno M-P, Poignet J-L, Albertazzi A, Haeffner-Cavaillon N. A major role for CD62P/CD15s interaction in leukocyte margination during hemodialysis. Kidney Int. 1995;48:93-102.
4. Kaupke CJ, Zhang J, Cesario T, Yoursefi S, Akeel N, Vaziri ND. Effect of hemodialysis on leukocyte adhesion receptor expression. Am. J. Kidney Dis. 1996;27:244-252.
5. Tabor B, Geissler B, Odell R, Schmidt B, Blumenstein K. Dialysis neutropenia: the role of the cytoskeleton. Kidney Int. 1998;53:783-789.
6. Hakim RM. Clinical implications of hemodialysis membrane biocompatibility. Kidney Int. 1993;44:484-494.
7. Combe C, Pourtein M, de Precigout V, et al. Granulocyte activation and adhesion molecules during hemodialysis with cuprophane and a high flux biocompatible membrane. Am. J. Kidney Dis. 1994;24:437-442.
8. Kawabata K, Nagake Y, Shikata K, Makino H, Ota Z. The changes of Mac-1 and L-selectin expression on granulocytes and soluble L-selectin level during hemodialysis. Nephron. 1996;73:573-579.
9. Passlick B, Flieger D, Ziegler-Heitbrock HWL. Identification and characterization of a novel monocyte subpopulation in human peripheral blood. Blood 1989;74:2527-2534.
10. Ziegler-Heitbrock HWL. Heterogeneity of human blood monocytes: the CD14+CD16+ subpopulation. Immunol. Today 1996;17:424-428.
11. Ziegler-Heitbrock HWL, Fingerle G, Strobel M, Schraut W, Stelter F, Schuttc Passlick B, Pforte A. The novel subset of CD14+CD16+ blood monocytes exhibit features of tissue macrophages. Eur. J. Immunol. 1993;23:2053-2058.
12. Sester U, Sester M, Kaul H, Girndt M, Kohler H. Strong depletion of CD14+CD16+ monocytes during hemodialysis treatment. Nephrol. Dial. Transplant. 2001;16:1402-1408.
13. Descamps-Latcha B, Herbelin A. Long term dialysis and cellular immunity: a critical survey. Kidney Int. 1993;43:135-142.
14. Chatenoud L, Jungers P, Descamps-Latcha B. Immunological considerations of the uremic and dialyzed patient. Kidney Int. 1994;45:92-96.
15. Gibbons RAS, Martinez OM, Garovoy MR. Altered monocyte function in uremia. Clin. Immunol. Immunopathol. 1990;56:66-80.
16. Ando M, Lundkvist I, Bergstrom J, Lindholm B. Enhanced scavenger receptor expression in monocyte-macrophages in dialysis patients. Kidney Int. 1996;49:773-780.
17. Mege JL, Capo C, Purgus R, Olmer M. Monocyte production of transforming growth factor beta in long-term hemodialysis: modulation by hemodialysis membranes. Am. J. Kidney Dis. 1996;28:395-399.
18. Girndt M, Sester U, Kaul H, Koehler H. Production of proinflammatory and regulatory monokines in hemodialysis patients shown at a single-cell level. J. Am. Soc. Nephrol. 1998;9:1689-1696.
19. Toren M, Goffinet JA, Kaplow LS. Pulmonary bed sequestration of neutrophils during hemodialysis. Blood 1970;36:337-340.
20. Nockher WA, Wiemer J, Scherberich JE. Hemodialysis monocytopenia: differential sequestration kinetics of CD14+CD16+ and CD14+ blood monocyte subsets. Clin. Exp. Immunol. 2001;123:49-55.
21. Steppich B, Ziegler-Heirtbrock HWL. Preferential localization of CD14+CD16+ monocytes in the marginal pool. Immunobiology 1998;199:555.
22. Steppich B, Dayyani F, Gruber R, Lorenz R, Mack M, Ziegler-Heirtbrock HWL. Selective mobilization of CD14+CD16+ monocytes by exercise. Am. J. Physiol. Cell. Physiol. 2000;279:578-586.
23. Springer TA. Traffic signals for lymphocyte recirculation and leukocyte emigration: multistep paradigm. Cell 1994;76:301-314.
24. Gabriel HH, Kindermann W. Adhesion molecules during immune response to exercise. Can. J. Physiol. Pharmacol. 1998;76:512-523.
25. Zaoui P, Hakim R. Natural killer cell function in hemodialysis patients: effect of the dialysis membrane. Kidney Int. 1993;43:1298-1305.
26. Grooteman MPC, Nube MJ, van Limbeek J, Schoorl M, van Houte AJ. Lymphocyte subsets in dialyzer eluates: a new parameter of biocompatibility? Nephrol. Dial. Transplant. 1996;11:1073-1078.
27. Kay NE, Raij L. Differential effect of hemodialysis membranes on human lymphocyte natural killer function. Artif. Organs 1987;11(2):165-167.
28. Stefoni S, Nanni-Costa A, Buscaroli A, et al. Cellular immunology in regular dialysis: a biological model for biocompatibility evaluation. Nephrol. Dial. Transplant. 1991;6:4-9.